Non‑small cell lung cancer carrying PBRM1 mutation suggests an immunologically cold phenotype leading to immunotherapy failure even with high TMB.
Miao XY, Wu H, Ye BC, Yi QW, Lin FN, Wang YL, Ren CL, Jiang YF, Li A. Sci Rep. 2022 Dec 1; 12(1):20734. Epub 2022 Dec 1.